200 related articles for article (PubMed ID: 18408767)
1. PCDH8, the human homolog of PAPC, is a candidate tumor suppressor of breast cancer.
Yu JS; Koujak S; Nagase S; Li CM; Su T; Wang X; Keniry M; Memeo L; Rojtman A; Mansukhani M; Hibshoosh H; Tycko B; Parsons R
Oncogene; 2008 Aug; 27(34):4657-65. PubMed ID: 18408767
[TBL] [Abstract][Full Text] [Related]
2. Frequent silencing of protocadherin 8 by promoter methylation, a candidate tumor suppressor for human gastric cancer.
Zhang D; Zhao W; Liao X; Bi T; Li H; Che X
Oncol Rep; 2012 Nov; 28(5):1785-91. PubMed ID: 22941331
[TBL] [Abstract][Full Text] [Related]
3. Protocadherin8 is a functional tumor suppressor frequently inactivated by promoter methylation in nasopharyngeal carcinoma.
He D; Zeng Q; Ren G; Xiang T; Qian Y; Hu Q; Zhu J; Hong S; Hu G
Eur J Cancer Prev; 2012 Nov; 21(6):569-75. PubMed ID: 22273848
[TBL] [Abstract][Full Text] [Related]
4. Expression of protocadherin8: Function as a tumor suppressor in hypopharyngeal carcinoma.
Li Y; Liu C; Wang Z; Hu G
Cancer Biomark; 2018; 22(3):495-502. PubMed ID: 29865037
[TBL] [Abstract][Full Text] [Related]
5. Low Expression of Protocadherin-8 Promotes the Progression of Ovarian Cancer.
Cao Y; Yu Y; Chen X; Ren F; Zhang R; Jia Y; Ren Z; Sun R; Li J; Shi H
Int J Gynecol Cancer; 2018 Feb; 28(2):346-354. PubMed ID: 29324532
[TBL] [Abstract][Full Text] [Related]
6. HOXA5 determines cell fate transition and impedes tumor initiation and progression in breast cancer through regulation of E-cadherin and CD24.
Teo WW; Merino VF; Cho S; Korangath P; Liang X; Wu RC; Neumann NM; Ewald AJ; Sukumar S
Oncogene; 2016 Oct; 35(42):5539-5551. PubMed ID: 27157614
[TBL] [Abstract][Full Text] [Related]
7. Functional epigenetics identifies a protocadherin PCDH10 as a candidate tumor suppressor for nasopharyngeal, esophageal and multiple other carcinomas with frequent methylation.
Ying J; Li H; Seng TJ; Langford C; Srivastava G; Tsao SW; Putti T; Murray P; Chan AT; Tao Q
Oncogene; 2006 Feb; 25(7):1070-80. PubMed ID: 16247458
[TBL] [Abstract][Full Text] [Related]
8. Protocadherin 8 (PCDH8) Inhibits Proliferation, Migration, Invasion, and Angiogenesis in Esophageal Squamous Cell Carcinoma.
Yu H; Jiang X; Jiang L; Zhou H; Bao J; Zhu X; Liu F; Huang J
Med Sci Monit; 2020 Apr; 26():e920665. PubMed ID: 32330123
[TBL] [Abstract][Full Text] [Related]
9. CDH1 promoter hypermethylation and E-cadherin protein expression in infiltrating breast cancer.
Caldeira JR; Prando EC; Quevedo FC; Neto FA; Rainho CA; Rogatto SR
BMC Cancer; 2006 Mar; 6():48. PubMed ID: 16512896
[TBL] [Abstract][Full Text] [Related]
10. Identification of Fat4 as a candidate tumor suppressor gene in breast cancers.
Qi C; Zhu YT; Hu L; Zhu YJ
Int J Cancer; 2009 Feb; 124(4):793-8. PubMed ID: 19048595
[TBL] [Abstract][Full Text] [Related]
11. Nemo-like kinase 1 (Nlk1) and paraxial protocadherin (PAPC) cooperatively control Xenopus gastrulation through regulation of Wnt/planar cell polarity (PCP) signaling.
Kumar R; Ciprianidis A; Theiß S; Steinbeißer H; Kaufmann LT
Differentiation; 2017; 93():27-38. PubMed ID: 27875771
[TBL] [Abstract][Full Text] [Related]
12. Aberrant methylation and silencing of ARHI, an imprinted tumor suppressor gene in which the function is lost in breast cancers.
Yuan J; Luo RZ; Fujii S; Wang L; Hu W; Andreeff M; Pan Y; Kadota M; Oshimura M; Sahin AA; Issa JP; Bast RC; Yu Y
Cancer Res; 2003 Jul; 63(14):4174-80. PubMed ID: 12874023
[TBL] [Abstract][Full Text] [Related]
13. Clinical significance of protocadherin 8 (PCDH8) promoter methylation in non-muscle invasive bladder cancer.
Lin YL; Wang YL; Ma JG; Li WP
J Exp Clin Cancer Res; 2014 Aug; 33(1):68. PubMed ID: 25927589
[TBL] [Abstract][Full Text] [Related]
14. CDH4 as a novel putative tumor suppressor gene epigenetically silenced by promoter hypermethylation in nasopharyngeal carcinoma.
Du C; Huang T; Sun D; Mo Y; Feng H; Zhou X; Xiao X; Yu N; Hou B; Huang G; Ernberg I; Zhang Z
Cancer Lett; 2011 Oct; 309(1):54-61. PubMed ID: 21665361
[TBL] [Abstract][Full Text] [Related]
15. Loss of expression and aberrant methylation of the CDH13 (H-cadherin) gene in breast and lung carcinomas.
Toyooka KO; Toyooka S; Virmani AK; Sathyanarayana UG; Euhus DM; Gilcrease M; Minna JD; Gazdar AF
Cancer Res; 2001 Jun; 61(11):4556-60. PubMed ID: 11389090
[TBL] [Abstract][Full Text] [Related]
16. Protocadherin-8 promotes invasion and metastasis via laminin subunit γ2 in gastric cancer.
Lin Y; Ge X; Zhang X; Wu Z; Liu K; Lin F; Dai C; Guo W; Li J
Cancer Sci; 2018 Mar; 109(3):732-740. PubMed ID: 29325230
[TBL] [Abstract][Full Text] [Related]
17. E-cadherin binding modulates EGF receptor activation.
Fedor-Chaiken M; Hein PW; Stewart JC; Brackenbury R; Kinch MS
Cell Commun Adhes; 2003; 10(2):105-18. PubMed ID: 14681060
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of CCN6 (Wnt-1-induced signaling protein 3) down-regulates E-cadherin in the breast epithelium through induction of snail and ZEB1.
Huang W; Zhang Y; Varambally S; Chinnaiyan AM; Banerjee M; Merajver SD; Kleer CG
Am J Pathol; 2008 Apr; 172(4):893-904. PubMed ID: 18321996
[TBL] [Abstract][Full Text] [Related]
19. Protocadherin 17 functions as a tumor suppressor suppressing Wnt/β-catenin signaling and cell metastasis and is frequently methylated in breast cancer.
Yin X; Xiang T; Mu J; Mao H; Li L; Huang X; Li C; Feng Y; Luo X; Wei Y; Peng W; Ren G; Tao Q
Oncotarget; 2016 Aug; 7(32):51720-51732. PubMed ID: 27351130
[TBL] [Abstract][Full Text] [Related]
20. Inactivation of human SRBC, located within the 11p15.5-p15.4 tumor suppressor region, in breast and lung cancers.
Xu XL; Wu LC; Du F; Davis A; Peyton M; Tomizawa Y; Maitra A; Tomlinson G; Gazdar AF; Weissman BE; Bowcock AM; Baer R; Minna JD
Cancer Res; 2001 Nov; 61(21):7943-9. PubMed ID: 11691816
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]